Recursion has hit 4 milestones in its Sanofi partnership over the last 18 months, as well as 1 with Roche. Recursion's ATM facility is also likely to be used opportunistically to raise cash.

Recursion Pharmaceuticals Inc. (NASDAQ: RXRX) is one of the best AI stocks to buy according to hedge funds. Earlier on June 6, a significant advancement in drug discovery was announced with the ...

Why Recursion Pharmaceuticals Was Bouncing Higher on Tuesday June 10, 2025 — 04:35 pm EDT Written by Eric Volkman for The Motley Fool -> ...

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) continues to have a pipeline of drugs that might provide further validation for the company's platform, but recent updates were not a roaring success.

During the last three months, 4 analysts shared their evaluations of Recursion Pharmaceuticals (NASDAQ:RXRX), revealing diverse outlooks from bullish to bearish. The table below provides a ...

Recursion Pharmaceuticals jumped by 31.3 percent week-on-week following the unveiling of Boltz-2, touted as the next-generation AI model to predict binding affinity. According to Recursion ...

Recently, two leading and long-established firms in the expanding AI drug discovery sector revealed an unexpected merger. In an approximate 75-25 agreement, Recursion Bio and Exscientia are set to ...

The command line is not only powerful, it can also be dangerous. Learn how to use commands for deleting files and folders correctly to make sure your time with Terminal is a productivity godsend ...